{"name":"Anokion SA","slug":"anokion-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ANK-700","genericName":"ANK-700","slug":"ank-700","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ANK-700","genericName":"ANK-700","slug":"ank-700","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxPQUJBSF9PbmFwSkZBZlN2ZjUtTEQzRGtYUU1XZThRdDlWTDBDcG9Ha0t3WVdZNTdHNy1jRm5ta1BVdGR4dXY4MENIaHNNTzVUREl0WEhSSm52amd1Y0xXa1prVFBWRVpucXFwQ2RLWmNoTjZLN2lIcG0tY3RRMmRESVQ3Mzdyelp4M01rQmFwcnJhdGl4SXh4QkREZHMySVhRd0wzWmlocjB1Y0dQaEpuR2I5Si1fS0dCZ3VxSmwzSUxuTUhVZWFSQ0lVcURoWEZwWng1YWoyQV9TSU9RNmJTcmtLQlIxUGFURWJUbGluMFFVLWtYZi0yY3pVRjZXQ3pibXRGRndpY0hPblAxRUphZmlNcWVBY183blFvTmxBeWZRUQ?oc=5","date":"2025-12-10","type":"trial","source":"globenewswire.com","summary":"Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ - globenewswire.com","headline":"Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNMDN4NXd2QkhfQ2w1Y2J3bU1mU1o2bzBNdFF2UUNwOTNPRHlmcVM1eDhlTW4wempvSWE5THJrbThjR21yTE5GMVRBRHAwRWctaWt2aTRSMVZhcm1RQXVnQzltTER4QmJEbjdkSzI5QXJrekloaW01X0F4cjlCRms4ODViRmV4eGN6QnZoNWtwa0VNa2d4ZGdDWE9iUW55cGtuNEhOcUhWb0FEZw?oc=5","date":"2025-07-09","type":"pipeline","source":"Contract Pharma","summary":"Radiant Biotherapeutics Names Deborah Geraghty President & CEO - Contract Pharma","headline":"Radiant Biotherapeutics Names Deborah Geraghty President & CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5UNG0xRW9hRXRjWmFPRU0xQ0RLS1FsUFlnQnlUQzdhYVJidHZfSTY2dEVFMEdncVdocUUxVDNBVmJoS1g2bW9TMzlpc3RZTUkzT2xvb0FQc0JKamtuWUpXaG5CYllRdlhFRUJ6R3ZUWUVsZmRoVFJZQTZaZW8?oc=5","date":"2025-01-02","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPM1VqMkd4bW15LW1RM1FTNFEzNHktNWRhM2hXWUpmMkMtRnc0dEdnaUVoYm1lMEpEQlVQSjJZN2M2ZVd5RmNVRUhmTmpvc2k5eFFaZXQycUdONVVkQ0tucGJYNXJOajY1ZE9tczVIZUp5cUZhMjFWaUpSV2ptclN4ZGl6NmVidXc1ZmU0MzYxTUVfWUZveTVzOS16YXpXaUNVS0V6TUM5dFQwT1huMjRnYnJtQWdwMjNxLTNiMUQtSW1odlNFNWREbGY0Q0JvR2ZuZ2ZQajYxazVxQ1BXdnYwamZONEJ0RkNha1M1NGF1djZlZ0NKVGhiVG50RQ?oc=5","date":"2024-11-19","type":"pipeline","source":"PR Newswire","summary":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - PR Newswire","headline":"Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNYVZGb1d4SlV6bHhTQ0RSVURidk9lekxZR0JyZlM1OEFCcmNBcnpaNGZCZzdybERwZFNjb2VSSjJmWXJpdUMwbWMxZW93ZXY0SV8wUDRBSVRaaFRxeFpPNXFCZ3JqQUpwbEtWdFNEY2lPYURISVF2QmV4aG8zdmw0dlpxV0RFT3VnV29fRmdkdDd3WkVrM1VJaU5rb0J3aHdGbkhGeE0yRFM4clBOQWxGT0JaTFcxS3VlVHZzNHU1YjlhQlEtcG1OUjlzdEp1QjU5RlNBeXNlcHZJLVl6SVBONkdkTQ?oc=5","date":"2024-11-13","type":"pipeline","source":"PR Newswire","summary":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - PR Newswire","headline":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPbkdobWFuXzdITklNSHFEYVkxdXVRVjc1aWtJRmlSR3lXYzNfekVfWTkyM0ppaTAzZTVSQXRnNnFwOURqLUZzWW13SG1xMlY2QVZ1dk5UamJfYkhaVkVEUXp4YkMwcHpRazBsUTMwV1QwUVZkcVhQak1WRnlKQXRlODBoQk9SclFySGVoTUVZSGdNUmVIQldmZTZ1NjZXR010NmhHYmpqSUZvVU5KdmJ2Zk9TUVhkNzJjWDk2MWNWRklCQ0pS?oc=5","date":"2024-09-10","type":"pipeline","source":"PR Newswire","summary":"BTK Inhibitors Market to Observe Stunning Growth by 2034 | DelveInsight - PR Newswire","headline":"BTK Inhibitors Market to Observe Stunning Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPNXdYUFg1eDlzU2x3bTRHMEpJT0xMYm1PSWFOQWtQVkNOTVZ3ejJzR1I4SXFXbTJqaVNpcVY0UXVWaVBRVEtlQTEtUzZ0aldzTHM5R3NXQmlIdXpxWHhWemRjMVllejhkT1VlbXFvRGRWN0Z1Y2lJNm5NVVkxRGQzYUdiTEw2bGNsdTNkMy0wVGtvdFc4Ri1jVDJOd1BGUTRvZV9EX1VrNDk5NGNtRzVneVRqMGY?oc=5","date":"2023-09-21","type":"pipeline","source":"University of Chicago News","summary":"‘Inverse vaccine’ shows potential to treat multiple sclerosis, other autoimmune diseases - University of Chicago News","headline":"‘Inverse vaccine’ shows potential to treat multiple sclerosis, other autoimmune diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQb050Y2ZaLXZrNXBfVFBTNWZCQUVlamhWbVl6MVk1LUpfcVRITEstajJHR1U1cTdJbWVHUFdxUzF5UXNHcW9NZjZnMjY1ZE1kZDhTd0JqdUdObXFiaE91MFEyMnUwSW5XUE51OWlNU1pROUxiNEpFMUh6cS1qek5LYVUyS016ZF8zTWxUb1owNW54RlVqaEZNZ0poVkNxZFpvcGc3aEhmelNjbzZGVW1qbEplMHZsdC1oOUJGVF9WM3RqaXBUWTZvZ3JBQkp0MU9LLW9aTl9R?oc=5","date":"2023-09-13","type":"pipeline","source":"SciTechDaily","summary":"New Vaccine Can Completely Reverse Autoimmune Diseases Like Multiple Sclerosis, Type 1 Diabetes, and Crohn’s Disease - SciTechDaily","headline":"New Vaccine Can Completely Reverse Autoimmune Diseases Like Multiple Sclerosis, Type 1 Diabetes, and Crohn’s Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOOGpGOGEtYlNTeDkxc2JwWmx1cWdLTEYzOHlHWVFRZTZnVVVLclRuZjNpSTVCNktNenN0TGF3dnBGSVoxaS1VRnZfVFpHWkpYa3ptWm1UZVhiZXQ5aG44RVQ3TWRscFVWUlFJUkUzcDI4QlJXZkw5YVZVS2tHbzVWR0o3bnVrSTJCUDgwV2lzamtDbHQ2?oc=5","date":"2019-09-12","type":"deal","source":"BioWorld News","summary":"Anokion acquires its spin-out, raises $40M series B - BioWorld News","headline":"Anokion acquires its spin-out, raises $40M series B","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}